Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.69 USD | +4.45% | -5.01% | +177.57% |
05-10 | Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating | MT |
05-09 | Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+177.57% | 2.24B | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- VERA Stock
- News Vera Therapeutics, Inc.
- Vera Therapeutics Insider Bought Shares Worth $4,999,990, According to a Recent SEC Filing